Example: Heart Attack

Clinical Trials on Acute Non Lymphoblastic Leukemia

Total 2813 results

NCT04547062

Not yet recruiting

Monocentric Phase 1 Study With Escalation of Doses of Tocilizumab in Combination With Chemotherapy (Idarubicin and Cytarabine) in Patients With Acute Myeloblastic Leukemia (AML)

Conditions: Acute Myeloid Leukemia (AML)
NCT04543305

Recruiting

A Study of PRT1419 in Patients With Relapsed/Refractory Hematologic Malignancies

Conditions: Multiple Myeloma; Acute Myeloid Leukemia; Non Hodgkin Lymphoma; Myelodysplastic Syndromes
NCT04541277

Recruiting

Combined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive Chemotherapy

Conditions: Acute Myeloid Leukemia, in Relapsed or Refractory; Acute Myeloid Leukemia, Elderly, Unfit; Acute Myeloid Leukemia With Positive Minimal Residual Disease
NCT04537871

Recruiting

Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study

Conditions: Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Hematopoietic and Lymphoid Cell Neoplasm; Hodgkin Lymphoma; Myelodysplastic Syndrome; Non-Hodgkin Lymphoma; Plasma Cell Myeloma
NCT04532203

Recruiting

A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies

Conditions: Acute Lymphoblastic Leukemia; Non-Hodgkin's Lymphoma
NCT04532268

Recruiting

A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL

Conditions: Acute Lymphoblastic Leukemia; Non-hodgkin Lymphoma,B Cell
NCT04532281

Recruiting

A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies

Conditions: Acute Lymphoblastic Leukemia; Non-Hodgkin Lymphoma of Soft Tissue
NCT04530695

Not yet recruiting

Diagnosis and Treatment of Periodontal Disease in Patients With AML

Conditions: AML; Acute Myelogenous Leukemia
NCT04526795

Not yet recruiting

Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia

Conditions: Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Recurrent Acute Biphenotypic Leukemia; Recurrent Acute Lymphoblastic Leukemia; Recurrent Acute Myeloid Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Recurrent T-Cell Prolymphocytic Leukemia; Refractory Acute Biphenotypic Leukemia; Refractory Acute Lymphoblastic Leukemia; Refractory Acute Myeloid Leukemia; Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Refractory T-Cell Prolymphocytic Leukemia
NCT04526288

Not yet recruiting

CPX-351 Versus Immediate Donor Stem Cell Transplant for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease

Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome With Excess Blasts-2; Myeloid Neoplasm
NCT04518345

Not yet recruiting

TP-0903 for the Treatment of FLT3 Mutated Acute Myeloid Leukemia

Conditions: Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Acute Myeloid Leukemia
NCT04517175

Not yet recruiting

Could Ki-67 be Used as a Diagnostic or Prognostic Marker in Hemato-oncological Diagnostics?

Conditions: Myelodysplastic Syndromes; Acute Myeloid Leukemia; Myelodysplastic Syndrome/Neoplasm
NCT04511130

Recruiting

Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant

Conditions: Acute Myeloid Leukemia; Stem Cell Transplantation
NCT04512105

Not yet recruiting

Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia

Conditions: Acute Myeloid Leukemia; Chronic Lymphocytic Leukemia; AML, Adult; CLL; CLL, Relapsed; CLL, Refractory
NCT04509622

Not yet recruiting

A Study of Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine (LDAC) Injection to Assess Adverse Events in Adult Japanese Participants With Acute Myeloid Leukemia (AML)

Conditions: Acute Myeloid Leukemia (AML)
NCT04501120

Not yet recruiting

Study of APG2575 Single Agent and Combination Therapy in Patients With Relapsed/Refractory AML

Conditions: Relapsed/Refractory Acute Myeloid Leukaemia
NCT04500587

Not yet recruiting

Phase 1 Study of ZN-d5 as a Single Agent

Conditions: Acute Myeloid Leukemia; Non Hodgkin Lymphoma
NCT04493099

Not yet recruiting

Alvocidib in Combination With Decitabine and Venetoclax in Patients With Relapsed or Refractory AML or as Frontline Therapy in Unfit Patients With AML

Conditions: Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia
NCT04493164

Not yet recruiting

CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Conditions: Acute Myeloid Leukemia With Gene Mutations; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia
NCT04490707

Recruiting

Study of Azacytidine Combined With Lenalidomide As Maintenance Therapy Based on MRD Monitoring in AML

Conditions: Acute Myeloid Leukemia in Remission
NCT04487106

Recruiting

Azacitidine, Venetoclax, and Trametinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndrome

Conditions: Recurrent Acute Myeloid Leukemia; Recurrent Chronic Myelomonocytic Leukemia; Recurrent Myelodysplastic Syndrome; Refractory Acute Myeloid Leukemia; Refractory Chronic Myelomonocytic Leukemia; Refractory Myelodysplastic Syndrome
NCT04485052

Not yet recruiting

Efficacy and Safety Evaluation of IBI188 in Combination With Azacitidine in Treatment of Patients With Acute Myeloid Leukemia

Conditions: Acute Myeloid Leukemia
NCT04484532

Recruiting

Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers

Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome
NCT04478695

Not yet recruiting

Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia

Conditions: Relapsed or Refractory Acute Myeloid Leukemia
NCT04476199

Not yet recruiting

Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) With Newly Diagnosed AML Eligible for Allo-SCT

Conditions: Acute Myeloid Leukemia
NCT04477291

Not yet recruiting

A Study of CG-806 in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Conditions: Acute Myeloid Leukemia
NCT04473911

Recruiting

Haplo Peripheral Blood Sct In GVHD Prevention

Conditions: GVHD; AML; ALL; MDS; MPN; CMML; Hodgkin Lymphoma; Non Hodgkin Lymphoma; Blood Stem Cell Transplant Failure; Graft Vs Host Disease; Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndromes; Myeloproliferative Disorder; Chronic Myelomonocytic Leukemia; Chemosensitive Hodgkin Lymphoma
NCT04470947

Recruiting

Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies

Conditions: Advanced Lymphoma; Refractory Lymphoma; Refractory Leukemia; Refractory Acute Myeloid Leukemia; Refractory T-Cell Lymphoma
NCT04471064

Not yet recruiting

A Study of XY0206 Tablets in Patients With Relapsed / Refractory Acute Myeloid Leukemia

Conditions: Acute Myeloid Leukemia
NCT04464889

Recruiting

HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation

Conditions: Acute Myeloid Leukemia; Acute Lymphoid Leukemia; Myelodysplastic Syndromes; Myeloproliferative Disorders; Chronic Myeloid Leukemia; Myelofibrosis; Multiple Myeloma; Malignant Lymphoma
NCT04460950

Not yet recruiting

Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms

Conditions: Acute Myeloid Leukemia; Familial Acute Myeloid Leukemia; Myelodysplastic Syndromes
NCT04460963

Not yet recruiting

Role of Adrenomedullin in Leukemic Endosteal/Vascular Niches

Conditions: Acute Myeloid Leukemia
NCT04460235

Not yet recruiting

Immunogenicity of an Anti-pneumococcal Combined Vaccination in Acute Leukemia or Lymphoma

Conditions: Vaccine; Streptococcus Pneumoniae; Acute Myeloid Leukemia; Lymphoma, Non-Hodgkin
NCT04454580

Recruiting

Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Not Eligible for Intensive Chemotherapy

Conditions: Acute Myeloid Leukemia, Adult; Hypomethylating Agents; Venetoclax
NCT04450784

Not yet recruiting

ObServatory Children Acute RElated Therapy Leukemia

Conditions: Leukemia, Myeloid, Acute
NCT04452604

Not yet recruiting

Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19

Conditions: Acute Myeloblastic Leukemia; Acute Lymphoblastic Leukemia; SARS-CoV-2
NCT04446741

Recruiting

Molecular Diagnostic Platform for AML

Conditions: Acute Myeloid Leukemia (AML)
NCT04446052

Completed

Phase III rhu_GM-CSF + 3 Induction Regimens in Adults With Acute Non-Lymphocytic Leukemia

Conditions: Adult Patients (Over 55) With Acute Non-Lymphocytic Leukemia
NCT04443751

Not yet recruiting

A Safety and Efficacy Study of SHR-1702 Monotherapy in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Conditions: AML; MDS
NCT04435691

Recruiting

Magrolimab, Azacitidine, and Venetoclax for the Treatment of Acute Myeloid Leukemia

Conditions: Acute Myeloid Leukemia; Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia
NCT04429191

Recruiting

JSP191 Antibody Targeting Conditioning in MDS/AML Patients Undergoing Hematopoietic Cell Transplantation

Conditions: MYELODYSPLASTIC SYNDROME; MDS; ACUTE MYELOID LEUKEMIA; AML
NCT04425655

Not yet recruiting

Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia.

Conditions: Acute Myeloid Leukemia, Adult; AML; AML, Adult
NCT04424147

Enrolling by invitation

Efficacy and Safety of HVA Regimens as Salvage Treatment in rrAML

Conditions: Refractory Acute Myeloid Leukemia; Relapsed Acute Erythroid Leukemia; Salvage Treatment; HVA Regimen
NCT04415008

Recruiting

Efficacy of HAD Induction With Intensified Cytarabine in Newly-diagnosed CEBPA Double Mutated Acute Myeloid Leukemia

Conditions: CEBPA Double Mutation; Acute Myeloid Leukemia
NCT04406207

Not yet recruiting

Endogenous Retroviruses in Acute Myeloid Leukemia

Conditions: Leukemia, Myeloid
NCT04402541

Recruiting

Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome

Conditions: Acute Myeloid Leukemia, in Relapse; Myelodysplastic Syndromes
NCT04402723

Recruiting

Combination of Donafenib and Cytarabine/Daunorubicin in Relapsed AML

Conditions: Acute Myeloid Leukemia (AML)
NCT04395092

Not yet recruiting

Haplo-identical Natural Killer (NK) Cells to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)

Conditions: Acute Myeloid Leukemia (AML); Myelodysplastic Syndromes (MDS)
NCT04392310

Not yet recruiting

Outcomes of Acute Myeloid Leukemia Patients

Conditions: Acute Myeloid Leukemia
NCT04385290

Not yet recruiting

Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)

Conditions: Acute Myeloid Leukemia

COOKIE SETTINGS

Clinical Trials on Acute Non Lymphoblastic Leukemia